Treatment with a proton pump inhibitor improves glycaemic control in type 2 diabetic patients - a retrospective analysis.
We retrospectively studied whether treatment with esomeprazole improved HbA₁(c) levels in type 2 diabetic patients. We selected 21 patients who had been treated with esomeprazole for 11 ± 3 months and 21 controls. HbA₁(c) levels decreased in the esomeprazole-treated group. Our data indicate that proton pump inhibitors may improve glycaemic control in type 2 diabetic patients.
Hove
Karin D
KD
Steno Diabetes Center, Niels Steensens Vej 2, DK-2820 Gentofte, Denmark.
Færch
Kristine
K
Bödvarsdóttir
Thóra B
TB
Karlsen
Allan E
AE
Petersen
Jacob S
JS
Vaag
Allan
A
D000368:Aged; D000369:Aged, 80 and over; D001786:Blood Glucose; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D064098:Esomeprazole / Q000627:therapeutic use*; D005260:Female; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D054328:Proton Pump Inhibitors / Q000627:therapeutic use*; D012189:Retrospective Studies
D001786:Blood Glucose; D064098:Esomeprazole; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D054328:Proton Pump Inhibitors